Recorded Chinese product: 注射用盐酸溴己新注射用盐酸溴己新

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

溴己新是一种在国家药监局注册认定的药品。该药品含有溴己新-a5ae79ad等成分。

该药品关联的活性成分包括:溴己新Xiuji Xin。这些成分信息来自国家药监局数据库。

该药品标注的生产企业为:国药集团国瑞药业有限公司Chinese legal name: 国药集团国瑞药业有限公司。

您可以探索含有相同成分的其他药品:溴己新-a5ae79ad成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 注射用盐酸溴己新) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).

Active ingredients associated with this product: 溴己新Xiuji Xin.

Manufacturers recorded for this product: 国药集团国瑞药业有限公司Chinese legal name: 国药集团国瑞药业有限公司.

Explore other medicines containing the same ingredient: 溴己新 productsProducts containing this recorded ingredient.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 注射用盐酸溴己新Recorded Chinese product: 注射用盐酸溴己新
  • 剂型Dosage form: 注射剂Injection
  • 规格Specification: 4mg(以盐酸溴己新计)Recorded Chinese specification: 4mg(以盐酸溴己新计)

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 国药集团国瑞药业有限公司Chinese legal name: 国药集团国瑞药业有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H20051651

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H20051651

Manufacturer

Chinese legal name: 国药集团国瑞药业有限公司 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

English translation unavailable. The original Chinese source label remains available below.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字H20051651

生产企业

国药集团国瑞药业有限公司(国产)

适应症

本品主要用于慢性支气管炎及其他呼吸道疾病如哮喘、支气管扩张、矽肺等有黏痰不易咳出者。

用法用量

1.肌内注射:加注射用水2ml溶解,溶解后注射,一次4mg(1支),一日8~12mg(2~3支)。 2.静脉注射:用0.9%氯化钠注射液或5%葡萄糖注射用稀释后静脉滴注,一次4mg(1支),一日8~12mg(2~3支)。

不良反应

1. 轻微的不良反应偶有头痛、头昏、恶心、呕吐、胃部不适、腹痛、腹泻,减量或停药后可消失。可有血清转氨酶―过性升高的现象。2. 严重的不良反应:皮疹、遗尿。

禁忌

对本品过敏者禁用。

注意事项

1. 当药品性状发生改变时禁止使用。2. 胃溃疡者应慎用。

贮藏

密闭,在凉暗干燥处保存。

规格

4mg(以盐酸溴己新计)

证据Evidence

  • 批准文号: 国药准字H20051651
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.